Intuitive Surgical (NASDAQ:ISRG) Stock Price Expected to Rise, Truist Financial Analyst Says

Intuitive Surgical (NASDAQ:ISRG) had its price objective raised by equities research analysts at Truist Financial from $620.00 to $650.00 in a research report issued to clients and investors on Thursday, MarketBeat reports. The brokerage presently has a “buy” rating on the medical equipment provider’s stock. Truist Financial’s target price would suggest a potential upside of 13.54% from the stock’s previous close.

A number of other equities research analysts also recently commented on ISRG. UBS Group set a $600.00 price objective on shares of Intuitive Surgical and gave the company a “neutral” rating in a research report on Thursday, October 23rd. Rothschild & Co Redburn raised their price target on Intuitive Surgical from $610.00 to $615.00 and gave the company a “buy” rating in a report on Thursday, October 23rd. Daiwa Capital Markets lifted their price target on Intuitive Surgical from $510.00 to $550.00 and gave the company an “outperform” rating in a research note on Friday, October 24th. Zacks Research upgraded Intuitive Surgical from a “hold” rating to a “strong-buy” rating in a research report on Friday, October 24th. Finally, Evercore ISI raised their target price on Intuitive Surgical from $450.00 to $540.00 in a report on Wednesday, October 22nd. Two equities research analysts have rated the stock with a Strong Buy rating, sixteen have given a Buy rating, eight have issued a Hold rating and one has issued a Sell rating to the stock. According to MarketBeat.com, Intuitive Surgical has a consensus rating of “Moderate Buy” and a consensus price target of $611.08.

Intuitive Surgical Stock Performance

Shares of ISRG opened at $572.47 on Thursday. The stock has a market capitalization of $205.22 billion, a P/E ratio of 75.72, a P/E/G ratio of 5.16 and a beta of 1.68. Intuitive Surgical has a 1 year low of $425.00 and a 1 year high of $616.00. The company’s fifty day moving average is $541.48 and its two-hundred day moving average is $506.30.

Intuitive Surgical (NASDAQ:ISRG) last released its earnings results on Tuesday, October 21st. The medical equipment provider reported $2.40 EPS for the quarter, topping the consensus estimate of $1.99 by $0.41. The company had revenue of $2.51 billion during the quarter, compared to analysts’ expectations of $2.41 billion. Intuitive Surgical had a net margin of 28.58% and a return on equity of 15.08%. During the same quarter last year, the business earned $1.84 EPS. The business’s revenue was up 22.9% on a year-over-year basis. Sell-side analysts predict that Intuitive Surgical will post 6.43 EPS for the current year.

Insider Activity at Intuitive Surgical

In related news, EVP Myriam Curet sold 104 shares of the business’s stock in a transaction dated Wednesday, December 10th. The shares were sold at an average price of $559.90, for a total value of $58,229.60. The transaction was disclosed in a document filed with the SEC, which is available through this link. Also, insider Gary S. Guthart sold 22,806 shares of the stock in a transaction dated Monday, December 1st. The shares were sold at an average price of $570.89, for a total transaction of $13,019,717.34. Following the completion of the sale, the insider directly owned 2,694 shares in the company, valued at approximately $1,537,977.66. The trade was a 89.44% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Insiders sold 114,007 shares of company stock valued at $63,533,844 in the last 90 days. 0.70% of the stock is owned by corporate insiders.

Institutional Trading of Intuitive Surgical

Institutional investors and hedge funds have recently modified their holdings of the business. Advisors Management Group Inc. ADV acquired a new stake in shares of Intuitive Surgical in the third quarter valued at approximately $881,000. AIA Group Ltd lifted its stake in Intuitive Surgical by 32.8% in the 3rd quarter. AIA Group Ltd now owns 29,582 shares of the medical equipment provider’s stock valued at $13,230,000 after buying an additional 7,314 shares in the last quarter. Hudson Bay Capital Management LP grew its holdings in Intuitive Surgical by 13.0% during the 3rd quarter. Hudson Bay Capital Management LP now owns 65,132 shares of the medical equipment provider’s stock valued at $29,129,000 after buying an additional 7,502 shares during the last quarter. Alecta Tjanstepension Omsesidigt increased its position in Intuitive Surgical by 25.4% during the third quarter. Alecta Tjanstepension Omsesidigt now owns 212,800 shares of the medical equipment provider’s stock worth $95,160,000 after buying an additional 43,100 shares in the last quarter. Finally, Saranac Partners Ltd acquired a new position in shares of Intuitive Surgical in the third quarter worth $4,325,000. Hedge funds and other institutional investors own 83.64% of the company’s stock.

Trending Headlines about Intuitive Surgical

Here are the key news stories impacting Intuitive Surgical this week:

• Positive Sentiment: Truist raised its price target to $650 and maintains a Buy rating — the upgrade gives visible upside and likely underpins analyst-driven buying interest. Read More. Read More.
• Positive Sentiment: RBC publishes a bullish forecast and RBC Capital keeps an Outperform rating — another large broker calling for strong price appreciation, supporting momentum. Read More. Read More.
• Positive Sentiment: Robert W. Baird reaffirmed its Buy rating — adds to the cluster of brokerages staying constructive, which can sustain inflows. Read More.
• Positive Sentiment: ISRG received a mention on CNBC’s “Final Trades” — media highlights can drive short-term retail/intraday interest. Read More.
• Neutral Sentiment: Company reorganized its digital and AI leadership (effective Jan 1) — signals focus on software/AI strategy but execution and timing are uncertain. Read More.
• Neutral Sentiment: ISRG plans to move to direct distribution in Southern Europe in 2026 to capture distributor economics — could lift margins if executed well, but the analyst note flags execution risk. Read More.
• Neutral Sentiment: Analyst consensus remains a “Moderate Buy” across brokerages — broad support, but not unanimous conviction; reinforces the view of steady analyst backing. Read More.
• Negative Sentiment: Valuation questions after a ~27% three‑month share-price climb — coverage is asking whether ISRG is still undervalued, raising the risk of short-term profit-taking given elevated multiples. Read More.

Intuitive Surgical Company Profile

Intuitive Surgical, founded in 1995 and headquartered in Sunnyvale, California, is a medical technology company focused on the design, manufacture and service of robotic-assisted surgical systems. The company is best known for its da Vinci surgical systems, which enable minimally invasive procedures by translating a surgeon’s hand movements into finer, scaled motions of small instruments inside the patient. Intuitive’s business centers on supplying hospitals and surgical centers with systems, instruments and related technologies that aim to improve precision, visualization and control in the operating room.

In addition to its core surgical platforms, Intuitive markets a portfolio of reusable and disposable instruments, accessories, and proprietary software, and provides training, servicing and clinical support to its customers.